Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk

NCT00138970 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Recipients

Interventions

DRUG: Zenapax®, CellCept® and prednisolone
DRUG: Sandimmun Neoral®, CellCept® and prednisolone

Sponsor

University of Oslo School of Pharmacy